makerware v. 2.4.1 (MakerBot Industries)
Structured Review
Makerware V. 2.4.1, supplied by MakerBot Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3d+printer+preform+software/makerware+version+2+4+0+17/pm26473653-71-24-30
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment. Article Snippet: A caplet, 10 × 4 × 3.6 mm (L × W × H) was designed and imported into the Article Title: Multienzyme chemiluminescent foldable biosensor for on-site detection of acetylcholinesterase inhibitors. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Solid forms and methods of preparing the same Article Snippet: The design was imported to the 3D printer's software, Article Title: Solid dosage form production Article Snippet: The design was imported to the 3D printer's software, Article Title: Solid forms and methods of preparing the same Article Snippet: The design was imported to the 3D printer's software, Article Title: The use of near-infrared as process analytical technology (PAT) during 3D printing tablets at the point-of-care. Article Snippet: Fused deposition modelling (FDM) is one of the most researched 3D printing technologies that holds great potential for low-cost manufacturing of personalised medicine.. To achieve real-time release, timely quality control is a major challenge for applying 3D printing technologies as a point-of-care (PoC) manufacturing approach.. This work proposes the use of a low-cost and compact near-infrared (NIR) spectroscopy modality as a process analytical technology (PAT) to monitor a critical quality attribute (drug content) during and after FDM 3D printing process. Article Title: 3D-printed immediate release solid dosage forms: a patent evaluation of US11622940B2. Article Snippet: ISSN: (Print) (Online) Journal homepage: www.tandfonline.com/journals/ippa20 3D-printed immediate release solid dosage forms: a patent evaluation of US11622940B2 Akshay Sharma, Ritu Rathi, Sanchay Sharma, Tanikan Sangnim, Kampanart Huanbutta & Inderbir Singh To cite this article: Akshay Sharma, Ritu Rathi, Sanchay Sharma, Tanikan Sangnim, Kampanart Huanbutta & Inderbir Singh (2024) 3D-printed immediate release solid dosage forms: a patent evaluation of US11622940B2, Pharmaceutical Patent Analyst, 13:1-3, 45-51, DOI: 10.1080/20468954.2024.2389774 To link to this article: https://doi.org/10.1080/20468954.2024.2389774 Article Title: Solid dosage form production Article Snippet: The design was imported to the |
